Igm Biosciences Inc (IGMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Sales | 372 | 331 | 366 | 0 | 0 |
| Gross Profit | 372 | 331 | 366 | N/A | N/A |
| Operating Expenses | 56,636 | 60,843 | 59,590 | 51,956 | 50,680 |
| Operating Income | -56,264 | -60,512 | -59,224 | -51,956 | -50,680 |
| Other Income | 3,688 | 2,475 | 629 | 62 | 38 |
| Pre-tax Income | -52,576 | -58,037 | -58,595 | -51,894 | -50,642 |
| Net Income Continuous | -52,576 | -58,037 | -58,595 | -51,894 | -50,642 |
| Net Income | $-52,576 | $-58,037 | $-58,595 | $-51,894 | $-50,642 |
| EPS Basic Total Ops | -1.14 | -1.32 | -1.33 | -1.53 | -1.50 |
| EPS Basic Continuous Ops | -1.14 | -1.32 | -1.33 | -1.53 | -1.50 |
| EPS Diluted Total Ops | -1.14 | -1.32 | -1.33 | -1.53 | -1.50 |
| EPS Diluted Continuous Ops | -1.14 | -1.32 | -1.33 | -1.53 | -1.50 |
| EBITDA(a) | $-56,353 | $-59,923 | $-57,751 | $-50,567 | $-49,239 |